Sanofi India Limited — Board Meeting, 16-07-2025: Outcome of Board Meeting

Sanofi India has announced a board meeting where key strategic decisions were made. The board approved the appointment of Mr. Rachid Ayari, current CFO, as Interim Managing Director for six months, pending shareholder approval. This move follows a review by the Nomination and Remuneration Committee. Mr. Aniket Raje was also appointed Head of Regulatory Affairs. In a significant operational update, Sanofi India entered an exclusive 5-year distribution and promotion agreement with Emcure Pharmaceuticals for its Oral Anti-diabetic drugs, including Amaryl® and Cetapin®. Sanofi will retain ownership and manufacturing, while Emcure will boost market reach. This aims to expand access to crucial diabetes treatments across India.